The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,949.00
Bid: 1,952.00
Ask: 1,954.00
Change: -24.00 (-1.22%)
Spread: 2.00 (0.102%)
Open: 1,972.00
High: 1,982.00
Low: 1,949.00
Prev. Close: 1,973.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: LSEG says Refinitiv savings bigger, ahead of schedule

Thu, 03rd Mar 2022 08:28

(Alliance News) - London Stock Exchange Group on Thursday said 2021 was a successful year following the acquisition of Refinitiv, leaving the stock exchange operator well positioned as a financial market infrastructure and data business.

For 2021, LSEG generated total income of GBP6.81 billion, up from a pro-forma GBP6.77 billion in 2020. Gross profit rose to GBP6.24 billion from GBP6.16 billion on the same basis. Adjusted pretax profit was GBP2.30 billion, up 27% from GBP1.81 billion. Statutory pretax profit was GBP987m, up from GBP492m.

LSEG declared a final dividend of 70 pence per share, a 27% increase in full year dividend to 95 pence per share, reflecting its strong performance in the year and confidence in outlook.

"The group has delivered a strong financial and operating performance in the first year following the successful completion of the acquisition of Refinitiv, with good revenue growth across all of our businesses. We are making excellent progress on integration and are on track to meet or exceed all the acquisition targets. We have established our position as a leading global market infrastructure and data business, and we carry good momentum into 2022," said Chief Executive Officer David Schwimmer.

LSEG said cost synergies following the Refinitiv acquisition were running ahead of target, with GBP151 million in annual run-rate achieved in 2021. It has identified an additional GBP50 million in cost synergies, raising its five-year target to at least GBP400 million.

LSEG shares were up 9.4% early Thursday.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: called up 0.4% at 7,460.10

----------

Hang Seng: up 0.6% at 22,467.34

Nikkei 225: closed up 0.7% at 26,577.27

S&P/ASX 200: closed up 0.5% at 7,151.40

----------

DJIA: closed up 596.40 points, 1.8%, at 33,891.35

S&P 500: closed up 1.9% at 4,386.54

Nasdaq Composite: closed up 1.6% at 13,752.02

----------

EUR: down at USD1.1098 (USD1.1130)

GBP: up at USD1.3400 (USD1.3363)

USD: firm at JPY115.68 (JPY115.60)

Gold: up at USD1,929.01 per ounce (USD1,923.31)

Oil (Brent): up at USD116.98 a barrel (USD109.94)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

Thursday's key economic events still to come

0955 CET Germany services purchasing managers' index

1000 CET EU eurozone services PMI

1100 CET EU producer price index

1100 CET EU unemployment

1300 CET EU ECB meeting accounts

0930 GMT UK services PMI

0830 EST US initial jobless claims

0945 EST US services PMI

1000 EST US ISM report on business services PMI

1000 EST US Fed Chair Powell presents Monetary Policy Report to Congress

1030 EST US EIA weekly natural gas storage report

----------

Russian forces have taken the Black Sea port of Kherson in southern Ukraine, the first major city to fall after a string of setbacks for Moscow. Russia's invasion so far has been astonishingly badly managed, a blundering "disaster, through and through", US defence experts said. It is like Moscow "tripped over the doorframe on the way into the house," one expert said, citing food and fuel shortages, poor intelligence and planning. Ukraine's second city Kharkiv continues to come under heavy Russian shelling, with police and university buildings among the latest struck.

----------

Ratings agencies Fitch and Moody's slashed Russia's sovereign debt to "junk" status, or the category of countries at risk of not being able to repay their debt, a week after Moscow began its assault on Ukraine. Moody's downgraded the rating on Russian long-term debt from Baa3 to B3 subject to a further review over the West's sanctions against Russia, while Fitch lowered its rating from BBB to B, also with a negative outlook. "The multi-notch downgrade of Russia's ratings and maintaining the review for further downgrade were triggered by the severe sanctions that Western countries have imposed on Russia", including on its central bank and some large financial institutions, Moody's said in a statement. The agency also noted a "heightened risk of disruption" to sovereign debt repayment in the face of "severe and coordinated sanctions".

----------

China's service sector slowed at the slowest rate for six months in February, survey data showed, though businesses expressed a stronger optimism for the year ahead. The seasonally adjusted headline business activity index slipped to 50.2 in February from 51.4 in January, signalling only a marginal rise in services activity.

----------

Service providers in Ireland reported the fastest growth in new business in six years, as overall business activity hit a four-month high in February, according to survey results released by IHS Markit. The AIB services business activity index jumped to 61.8 points in February from 56.2 in January, as Covid-19 restrictions were lifted in Ireland. The reading was the highest in four months and well above the long-run average of 55.0 points. The month-on-month acceleration in growth was the sharpest on record, IHS Markit said. The strong services score lifted the AIB Ireland composite purchasing managers' index to 59.1 in February from 56.1 in January, overcoming a decline in the factory sector reading. On Tuesday, IHS Markit had said the manufacturing PMI score was 57.8 points last month, down from 59.4 in January.

----------

BROKER RATING CHANGES

----------

Morgan Stanley cuts Hikma Pharmaceutical to 'equal-weight' ('overweight') - price target 2,300 (2,800) pence

----------

JPMorgan resumes SSP with 'overweight'

----------

COMPANIES - FTSE 100

----------

Housebuilder Taylor Wimpey said it delivered a strong 2021 performance with results in line with its expectations. For 2021, it posted pretax profit GBP679.6 million, up from GBP264.4 million in 2020 on revenue of GBP4.28 billion, up from GBP2.79 billion. 2021 saw a 47% increase in UK completions including joint ventures to 14,087, up from 9,609 in 2020, driven by good build performance and strong demand. Taylor Wimpey declared a final dividend of 4.44 pence for 8.58p total, up from 4.14p in 2020. It also plans GBP150 million share buyback in 2022 to return excess cash. Looking ahead, the company continues to expect to deliver low single-digit year-on-year completions growth in 2022 and to make further progress towards 21% to 22% operating margin target. Its operating margin in 2021 was 19.3%, up from 10.8% in 2020. Taylor Wimpey expects 2022 year-end net cash to be around GBP600 million, depending on the timing of land payments. "With the opportunistic purchase of additional land over the last 18 months, our land pipeline leaves us well placed to accelerate high-quality, profitable volume delivery from 2023, generating additional value and compelling investor returns," said Chief Executive Officer Pete Redfern.

----------

CRH said 2021 was another year of record delivery for the Dublin-based building materials firm, with continued strong cash generation and profit growth. For 2021, CRH posted pretax profit of USD3.34 billion, doubled from USD1.66 billion in 2020 on revenue of USD30.98 billion, up 12% from USD27.59 billion. CRH generated record net cash flows from operating activities of USD4.2 billion in 2021, up from USD3.9 billion in 2020. CRH declared a final dividend of 98.0 US cents per share, resulting in a total dividend of 121.0 cents for the year, up from 115.0 cents in 2020. Looking ahead, CRH expects underlying demand and pricing backdrop to remain favourable in 2022 albeit against an inflationary input cost environment and continued supply chain challenges. Federal funding for infrastructure is underpinned by the passing of the USD1.2 trillion infrastructure package by the US Congress, while the US residential market is expected to continue to grow driven by robust demand, it added.

----------

Coca-Cola HBC revoked its 2022 financial guidance due to the conflict between Russia and Ukraine, two of its key sales territories. The soft drinks bottler noted that 20% of its 2021 volumes and earnings before interest and tax came from the two countries. It temporarily stopped product at its plant in Kyiv on February 24 and evacuated its employees. Coca-Cola HBC said it will use management actions to mitigate the headwinds outside its control and is ready to redeploy marketing spend and capital expenditure to other markets.

----------

Investment manager Schroders said pretax profit jumped by 25% in 2021 to GBP764.1 million from GBP610.5 million in 2020, as net income rose by 18% to GBP2.57 billion from GBP2.18 billion. Schroders hiked its annual dividend by 7.0% to 122.0 pence from 114.0p. "After a period of benign markets there is a risk that the current turbulence will be with us for some while," the company said.

----------

Thursday's shareholder meetings

Chemring Group PLC - AGM

Petro Matad Ltd - AGM

Zytronic PLC - AGM

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
20 Apr 2022 09:16

IN BRIEF: Hikma gets preliminary US approval for Custopharm acquisition

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Receives preliminary approval from the US Federal Trade Commission for its planned acquisition of Custopharm Inc. Back in September, Hikma agreed to buy the California, US-based generic injectable products company for a total of up to USD425 million.

Read more
20 Apr 2022 07:39

Hikma gets preliminary approval from US FTC for Custopharm deal

(Sharecast News) - Hikma Pharmaceuticals has received preliminary approval from the US Federal Trade Commission for the acquisition of sterile injectables company Custopharm Inc from Water Street Healthcare for up to $425m.

Read more
12 Apr 2022 10:11

LONDON BROKER RATINGS: JPMorgan lowers Rolls-Royce; UBS likes Ryanair

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
10 Mar 2022 16:10

UK dividends calendar - next 7 days

Friday 11 March  
Avon Protection PLCdividend payment date
Civitas Social Housing PLCdividend payment date
Impact Healthcare REIT PLCdividend payment date
Virgin Money UK PLCdividend payment date
Monday 14 March  
Tritax EuroBox PLCdividend payment date
Tuesday 15 March 
Hipgnosis Songs Fund Ltddividend payment date
Invesco Perpetual UK Smaller Cos Investment Trust PLCdividend payment date
Merchants Trust PLCdividend payment date
Wednesday 16 March  
no events scheduled 
Thursday 17 March  
Anglo American PLCex-dividend date
Anglo American PLCspecial ex-dividend date
Bellevue Healthcare Trust PLCex-dividend date
Blackrock Income & Growth Investment Trust PLCdividend payment date
BlacKRock World Mining Trust PLCex-dividend date
Brooks Macdonald Group PLCex-dividend date
Crest Nicholson Holdings PLCex-dividend date
Dunelm Group PLCex-dividend date
FW Thorpe PLCex-dividend date
FW Thorpe PLCspecial ex-dividend date
Gore Street Energy Storage Fund PLCex-dividend date
HgCapital Trust PLCex-dividend date
Hikma Pharmaceuticals PLCex-dividend date
Ideagen PLCdividend payment date
JPMorgan Mid Cap Investment Trust PLCex-dividend date
Knights Group Holdings PLCdividend payment date
M&G PLCex-dividend date
Murray Income Trust PLCdividend payment date
NatWest Group PLCex-dividend date
RM PLCex-dividend date
Segro PLCex-dividend date
Spirent Communications PLCex-dividend date
Standard Life Private Equity Trust PLCex-dividend date
Treatt PLCdividend payment date
Trifast PLCex-dividend date
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
3 Mar 2022 10:02

LONDON BROKER RATINGS: Downgrades for Hikma Pharma and Royal Mail

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
2 Mar 2022 09:52

LONDON BROKER RATINGS: Downgrades for AB Foods, BT and Royal Mail

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
25 Feb 2022 09:40

IN BRIEF: Hikma Pharmaceuticals launches first phase of share buyback

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Instructs Citigroup Global Markets Ltd, part of Citigroup Inc, to conduct the USD150 million first tranche of the USD300 million share buyback that it announced on Thursday. The initial phase will begin on Friday and end by June 25. Hikma had announced the buyback programme with its annual results, saying it reflected its strong cash generation, balance sheet strength, and confidence in future growth prospects. Hikma also had declared a final dividend of 36 cents, a 5.9% boost from a shareholder payout of 34 cents the year before. Its full-year dividend amounted to 54 US cents, up 8.0% from 50 cents.

Read more
25 Feb 2022 08:22

LONDON BRIEFING: IAG expects to fly 85% of pre-virus capacity in 2022

(Alliance News) - International Consolidated Airlines Group on Friday posted a narrowed loss for 2021, saying that after the setback caused by Omicron at the end of the year, bookings have rebounded strongly and it expects to fly 85% of its 2019 capacity in 2022.

Read more
24 Feb 2022 10:31

TOP NEWS: Hikma Pharmaceutical records revenue growth and lifts payout

(Alliance News) - Hikma Pharmaceutical PLC on Thursday reported full-year revenue growth on a "strong" performance by its three business segments and lifted its shareholder payout.

Read more
24 Feb 2022 07:58

Hikma Pharmaceutical delivers year of 'solid growth' and 'strategic momentum'

(Sharecast News) - Drugmaker Hikma Pharmaceutical said on Thursday that it had delivered another successful year of "solid growth and continued strategic momentum", with both revenue and operating profits improving year-on-year.

Read more
24 Feb 2022 07:50

LONDON MARKET PRE-OPEN: Share buybacks for Lloyds Banking and Hikma

(Alliance News) - Stock prices in London are seen opening sharply lower, with the FTSE 100 called down almost 200 points, amid fear of a full-scale war in eastern Europe after Russia announced the beginning of a military operation in Ukraine.

Read more
17 Feb 2022 16:08

UK earnings, trading statements calendar - next 7 days

Friday 18 February  
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 21 February 
Bank of Cyprus Holdings PLCFull Year Results
Dechra Pharmaceuticals PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Tristel PLCTrading Statement
Wilmington PLCHalf Year Results
Tuesday 22 February 
Antofagasta PLCFull Year Results
Bank of Georgia Group PLCFull Year Results
Benchmark Holdings PLCQ1 Results
Blancco Technology Group PLCHalf Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Coca-Cola HBC AGFull Year Results
Hargreaves Lansdown PLCHalf Year Results
HSBC Holdings PLCFull Year Results (at 0400 GMT)
InterContinental Hotels Group PLCFull Year Results
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Synectics PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wednesday 23 February 
Aston Martin Lagonda Global Holdings PLCFull Year Results
Barclays PLCFull Year Results
Capital & Counties Properties PLCFull Year Results
CAP-XX LtdHalf Year Results
Georgia Capital PLCFull Year Results
International Personal Finance PLCFull Year Results
Irish Residential Properties REIT PLCFull Year Results
Metro Bank PLCFull Year Results
Hochschild Mining PLCFull Year Results
Photo-Me International PLCFull Year Results
Rio Tinto PLCFull Year Results
Seraphim Space Investment Trust PLCHalf Year Results
Ted Baker PLCTrading Statement
Unite Group PLCFull Year Results
Thursday 24 February 
Anglo American PLCFull Year Results
BAE Systems PLCFull Year Results
Centrica PLCFull Year Results
Conduit Holdings LtdFull Year Results
Derwent London PLCFull Year Results
Drax Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Inchcape PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Rathbone Group PLCFull Year Results
Ricardo PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
St James's Place PLCFull Year Results
Tremor International LtdFull Year Results
WPP PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
9 Feb 2022 09:48

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

Read more
3 Feb 2022 09:12

Hikma completes acquisition of Teligent's Canadian assets

Hikma completes acquisition of Teligent's Canadian assets

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.